Leo Pharma's board now has one person less

The board of Leo Pharma has one less member after Novozymes' CFO Lars Green has been elected to replace two profiles who will not be rerunning.

Photo: Leo Pharma / PR

Danish businesswoman Cristina Lage, who has held multiple executive positions, is leaving Leo Pharma's board after four years.

So is former Novo Nordisk executive and now Ascendis employee Jesper Høiland, who has held a seat on the board since 2016.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs